ClinicalTrials.Veeva

Menu

Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU (PR-Covid-19)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Acute Respiratory Distress Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT04385004
7815 (Other Identifier)

Details and patient eligibility

About

Renal damage in patients hospitalized for ARDS in the ICU can also be related to multiple causes including, but not limited to, the consequences of hemodynamic fluctuations in these patients or the use of nephrotoxic drugs responsible for acute post-ischemic or toxic tubular necrosis. Frequently observed abnormalities of cioagumation may also have a potential impact on renal structures, particularly glomerular capillaries.

The researchers wish to characterize and phenotype the renal impairment of patients hospitalized in intensive care with tables of severe Covid19 infections in ARDS: clinical, biological and histological (by performing post-mortem biopsies).

Translated with www.DeepL.com/Translator (free version)

Enrollment

320 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over 18 years of age
  • Diagnosed Covid-19 by RT PCR
  • Hospitalized in intensive care for management of complications related to Covid-19 from March 1, 2020 to April 20, 2020
  • Patient not having expressed his or her opposition, after information, to the re-use of his or her data for the purposes of this research.

Exclusion criteria

  • Subject who expressed opposition to participating in the study

Trial contacts and locations

1

Loading...

Central trial contact

Saïd CHAYER, PhD, HDR; Ferhat MEZIANI, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems